- Filed
- May 23, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · May 9, 2025 | 149.44M sh |
| Cash And Equivalents | FY 2025 · Mar 31, 2024 | $1.5B |
| Current Liabilities | FY 2025 · Mar 31, 2024 | $719.99M |
| Current Assets | FY 2025 · Mar 31, 2024 | $2.44B |
| Total Assets | FY 2025 · Mar 31, 2024 | $3.14B |
| Shares Diluted restated | FY 2025 · Mar 31, 2023 | 160.11M sh |
| Stock Repurchased | FY 2025 · Mar 31, 2023 | $297.37M |
| Capex | FY 2025 · Mar 31, 2023 | $81.03M |
| Operating Cash Flow | FY 2025 · Mar 31, 2023 | $537.42M |
| Eps Diluted restated | FY 2025 · Mar 31, 2023 | $3.23 |
| Eps Basic restated | FY 2025 · Mar 31, 2023 | $3.25 |
| Sga Expense | FY 2025 · Mar 31, 2023 | $1.17B |
| Rd Expense | FY 2025 · Mar 31, 2023 | $38.66M |
| Net Income | FY 2025 · Mar 31, 2023 | $516.82M |
| Operating Income | FY 2025 · Mar 31, 2023 | $652.75M |
| Gross Profit | FY 2025 · Mar 31, 2023 | $1.83B |
| Cost Of Revenue | FY 2025 · Mar 31, 2023 | $1.8B |
| Revenue | FY 2025 · Mar 31, 2023 | $3.63B |
| Stockholders Equity | FY 2025 · Mar 31, 2022 | $1.54B |